Skip to main content
. 2025 Oct 12;43(1):607. doi: 10.1007/s00345-025-05968-9

Table 3.

Complications by Clavien-Dindo grade (I-V)

Author Reported Complications Grade I-II Grade III-IV Grade V
Benamran et al. 2022 [21] 2 (10%) 1 (Pain and Anxiety) 1 (Hematoma) 0
Bernhard et al. 2022 [19] 7 (8.5%) 7 (tramadol induced hallucinations, pain, nausea, anxiety, delayed voiding) 0 0
Gangidi et al. 2025 [9] 4 (9.1%) NA NA NA
Mehrazin et al. 2020 [18] 1 (4.3%), Urinary retention NA NA NA
Wald et al. 2024 [20] 1 (4.8%) 1 (Wound infection) 0 0
Wood et al. 2023 [11] NA NA NA NA